331 related articles for article (PubMed ID: 27603293)
1. Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.
Ásbjörnsdóttir KH; Hughes JP; Wamalwa D; Langat A; Slyker JA; Okinyi HM; Overbaugh J; Benki-Nugent S; Tapia K; Maleche-Obimbo E; Rowhani-Rahbar A; John-Stewart G
AIDS; 2016 Nov; 30(18):2835-2843. PubMed ID: 27603293
[TBL] [Abstract][Full Text] [Related]
2. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
Chiappini E; Galli L; Tovo PA; Gabiano C; Gattinara GC; Guarino A; Badolato R; Giaquinto C; Lisi C; de Martino M;
AIDS; 2006 Jan; 20(2):207-15. PubMed ID: 16511413
[TBL] [Abstract][Full Text] [Related]
3. The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children.
Soeters HM; Sawry S; Moultrie H; Rie AV
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):136-44. PubMed ID: 25072611
[TBL] [Abstract][Full Text] [Related]
4. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
[TBL] [Abstract][Full Text] [Related]
5. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
[TBL] [Abstract][Full Text] [Related]
7. Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.
Shiau S; Strehlau R; Technau KG; Patel F; Arpadi SM; Coovadia A; Abrams EJ; Kuhn L
AIDS; 2017 Jan; 31(3):355-364. PubMed ID: 27828785
[TBL] [Abstract][Full Text] [Related]
8. Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire.
Adjé-Touré C; Hanson DL; Talla-Nzussouo N; Borget MY; Kouadio LY; Tossou O; Fassinou P; Bissagnene E; Kadio A; Nolan ML; Nkengasong JN
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):911-7. PubMed ID: 18593341
[TBL] [Abstract][Full Text] [Related]
9. Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania.
Stete K; Glass TR; van Dam GJ; Ntamatungiro A; Letang E; de Dood CJ; Corstjens PLAM; Ndege R; Mapesi H; Kern WV; Hatz C; Weisser M; Utzinger J; Müller MC
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006844. PubMed ID: 30332404
[TBL] [Abstract][Full Text] [Related]
10. Recovery of effective HIV-specific CD4+ T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia.
Adland E; Mori L; Laker L; Csala A; Muenchhoff M; Swordy A; Mori M; Matthews P; Tudor-Williams G; Jooste P; Goulder P
AIDS; 2018 Jul; 32(11):1413-1422. PubMed ID: 29734220
[TBL] [Abstract][Full Text] [Related]
11. CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.
Fairlie L; Karalius B; Patel K; van Dyke RB; Hazra R; Hernán MA; Siberry GK; Seage GR; Agwu A; Wiznia A;
AIDS; 2015 Oct; 29(16):2109-19. PubMed ID: 26182197
[TBL] [Abstract][Full Text] [Related]
12. Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.
Krogstad P; Patel K; Karalius B; Hazra R; Abzug MJ; Oleske J; Seage GR; Williams PL; Borkowsky W; Wiznia A; Pinto J; Van Dyke RB;
AIDS; 2015 Mar; 29(6):683-93. PubMed ID: 25849832
[TBL] [Abstract][Full Text] [Related]
13. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
[TBL] [Abstract][Full Text] [Related]
14. Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.
Chohan BH; Tapia K; Benki-Nugent S; Khasimwa B; Ngayo M; Maleche-Obimbo E; Wamalwa D; Overbaugh J; John-Stewart G
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):783-91. PubMed ID: 25819584
[TBL] [Abstract][Full Text] [Related]
15. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
[TBL] [Abstract][Full Text] [Related]
16. The importance of caregivers in the outcome of pediatric HIV management, Mombasa, Kenya.
Sivapalasingam S; Mendillo M; Ahmed A; Mwamzuka M; Said S; Marshed F; Luhar Abdulaziz F; Fajans M; Holzman R
AIDS Care; 2014 Apr; 26(4):425-33. PubMed ID: 24090313
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
[TBL] [Abstract][Full Text] [Related]
18. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland.
Kekitiinwa A; Lee KJ; Walker AS; Maganda A; Doerholt K; Kitaka SB; Asiimwe A; Judd A; Musoke P; Gibb DM; ;
J Acquir Immune Defic Syndr; 2008 Dec; 49(4):384-92. PubMed ID: 18931630
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
Song R; Jelagat J; Dzombo D; Mwalimu M; Mandaliya K; Shikely K; Essajee S
Pediatrics; 2007 Oct; 120(4):e856-61. PubMed ID: 17846147
[TBL] [Abstract][Full Text] [Related]
20. Long-term effectiveness of combination antiretroviral therapy and prevalence of HIV drug resistance in HIV-1-infected children and adolescents in Rwanda.
Mutwa PR; Boer KR; Rusine J; Muganga N; Tuyishimire D; Schuurman R; Reiss P; Lange JM; Geelen SP
Pediatr Infect Dis J; 2014 Jan; 33(1):63-9. PubMed ID: 24352189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
